ReviewCardiovascular diagnosis and therapy2017
Coronary microvascular dysfunction in women with nonobstructive ischemic heart disease as assessed by positron emission tomography.
Review in Cardiovascular diagnosis and therapy, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed, 31 citations in OpenAlex.
- Paradoxical ST-segment depression at high blood flow in ANOCA: a hypothesis-generating analysis.The international journal of cardiovascular imaging · 2026Article
- A recurrent typical angina pectoris without any finding in coronary angiography: Microvascular angina.Clinical case reports · 2024Article
- INOCA: Ischemia in non-obstructive coronary arteries.American heart journal plus : cardiology research and practice · 2024Article
- Prevalence and characteristics of coronary microvascular dysfunction in post-percutaneous coronary intervention patients with recurrent chest pain.Cardiovascular diagnosis and therapy · 2022Article
- Coronary Microvascular Disease.Cardiology and therapy · 2022Review
- Coronary Microvascular Angina: A State-of-the-Art Review.Frontiers in cardiovascular medicine · 2022Review
- Coronary microvascular dysfunction as a chronic inflammatory state: Is there a role for omega-3 fatty acid treatment?American heart journal plus : cardiology research and practice · 2022Review
- Phenotypes of hypertrophic cardiomyopathy: genetics, clinics, and modular imaging.Heart failure reviews · 2021Review
- Ten things to know about ten imaging studies: A preventive cardiology perspective ("ASPC top ten imaging").American journal of preventive cardiology · 2021Review
- Metabolomics and cardiovascular imaging: a combined approach for cardiovascular ageing.ESC heart failure · 2021Review
- Coronary microvascular disease: current concepts of pathophysiology, diagnosis and management.Cardiovascular endocrinology & metabolism · 2021Review
- Diagnostic analysis of new quantitative parameters of low-dose dynamic myocardial perfusion imaging with CZT SPECT in the detection of suspected or known coronary artery disease.The international journal of cardiovascular imaging · 2021Article
- Clinical characteristics and biomarkers of coronary microvascular dysfunction and obstructive coronary artery disease.The Journal of international medical research · 2019Article
- Molecular Imaging of Factor XIII Activity for the Early Detection of Mouse Coronary Microvascular Disease.Theranostics · 2019Article
- Clinical significance of PET-CT coronary flow reserve in diagnosis of non-obstructive coronary artery disease.BMC research notes · 2018Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Traditional approaches for risk assessment of ischemic heart disease (IHD) are based on the physiological consequences of an epicardial coronary stenosis. Of note, normal coronary arteries or nonobstructive coronary artery disease (CAD) is a common finding in women with signs and symptoms of ischemia. Therefore, assessment of risk based on a coronary stenosis approach may fail in women. Positron emission tomography (PET) quantifies absolute myocardial blood flow (MBF) which may help to elucidate other mechanisms involved such as endothelial dysfunction and alterations in the smooth muscle cell relaxation responsible for IHD in women. The objective of the present review is to describe the current state of the art of PET imaging in assessing IHD in women with nonobstructive CAD.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.